TickerFactsScreenerDevelopers

VERTEX PHARMACEUTICALS INC / MA (VRTX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2007: $355.66M2008: $389.12M2009: $446.66M2010: $243.20M2011: $475.32M2012: $489.41M2013: $569.30M2014: $625.26M2015: $714.77M2016: $1.18B2017: $1.67B2018: $2.65B2019: $3.11B2020: $5.99B2021: $6.79B2022: $10.50B2023: $10.37B2024: $4.57B2025: $5.08B$5.08B
2007Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$5.08B+11.3%
2024$4.57B-55.9%
2023$10.37B-1.3%
2022$10.50B+54.6%
2021$6.79B+13.5%
2020$5.99B+92.6%
2019$3.11B+17.3%
2018$2.65B+59.1%
2017$1.67B+40.7%
2016$1.18B+65.6%
2015$714.77M+14.3%
2014$625.26M+9.8%
2013$569.30M+16.3%
2012$489.41M+3.0%
2011$475.32M+95.4%
2010$243.20M-45.6%
2009$446.66M+14.8%
2008$389.12M+9.4%
2007$355.66M—